Predict your next investment

INDUSTRIAL | Machinery & Equipment / Robotics

See what CB Insights has to offer

Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$660K | 4 mos ago

About Nanovery

Nanovery is developing nanorobots to diagnose the deadly diseases.

Nanovery Headquarter Location

Tower Bridge Business Complex 100 Drummond Road

London, England, SE16 4DG,

United Kingdom

Latest Nanovery News

Biotech company Nanovery moves to Newcastle science park to tap into regional talent

Sep 29, 2021

Biotech company Nanovery moves to Newcastle science park to tap into regional talent The firm which specialises in tech to improve the diagnosis of serious diseases has swapped London for Newcastle Helix 09:00, 29 SEP 2021 Left to right – Jurek Kozyra, co-founder and CEO of Nanovery, Luke Dunnett, property business manager at The Biosphere, coun Joyce McCarty, cabinet member for inclusive economy at Newcastle City Council. (Image: Nanovery/Newcastle City Council) Sign up to FREE email alerts from BusinessLive - Enterprise - good ideas, product development and SME news every ThursdayInvalid EmailSomething went wrong, please try again later. Subscribe We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info Thank you for subscribingWe have more newsletters Show me See our privacy notice A biotech company has moved into Newcastle science park Helix after leaving London to tap into regional talent. Nanovery specialises in nanorobotic technology to improve the diagnosis of some of the world’s most serious diseases, Formed in 2018, it is developing nanorobots for a quick and easy test to help diagnose cancer and other diseases. It says its tests, based on DNA nanotechnology, costs less than tissue biopsy, while reducing risk to patients. The company, which was launched in London, moved to Newcastle last year to collaborate and access some of the city’s most renowned academics and partners in the field of research and development, including Newcastle University and Newcastle Centre for Cancer. Now it has set up home in The Biosphere – Helix’s laboratory and office building dedicated to life science innovation, research, development, and commercialisation – in a move which is testament to Newcastle’s status as a leading UK city in those fields. The move has also allowed the company to recruit from the city’s local talent pool, with half of its workforce coming from the city since its relocation. Jurek Kozyra, co-founder and chief executive officer of Nanovery said: “Having learnt about the huge challenge around diagnostics with cancer early on in my career, I knew I wanted to start up a company that could work towards developing a more efficient diagnostics solution for serious diseases, with the goal to bring more regular testing to clinicians and patients. “Nanobots can detect cancer cells at a faster rate than current methods, and more efficiently than scans and biopsies which are often slow, expensive and come with a risk to patients. Adding our Nanorobots to blood samples makes the process more than 100 times faster, providing results in hours, as opposed to weeks. “We’re delighted to be joining Newcastle’s budding life science cluster on Newcastle Helix. Newcastle is a great place to build partnerships, even beyond the Centre of Cancer, who we are already working alongside. “There is incredible potential to grow and expand our team in The Biosphere and we look forward to networking and sharing knowledge and expertise amongst the variety of life science companies that exist in The Biosphere and North East.” Biosphere at Newcastle Helix (Image: Biosphere) Coun Joyce McCarty, cabinet member for inclusive economy at Newcastle City Council said: “We’re delighted to see Nanovery make Newcastle their home due to our outstanding resources in the sector including world-class research and development, happening across our universities, and the organisations that work to support life science start-ups and scale-ups. "The scale of start-ups that have chosen to make The Biosphere their base for innovation and invention over the last 12 months is proof that our city is leading the way in health and life science.” Luke Dunnett, property business manager at The Biosphere, added: “A huge welcome to Nanovery, whose work to improve the diagnosis of diseases such as cancer aims to make a difference not only in our country, but around the world. “They’ll be joining a range of established businesses and university spin-outs using cutting edge technology to help fight the many challenges faced in the health and medical industry. “We couldn’t be more proud of talent in our life science cluster and delighted to see more of our city’s people and graduates in the field getting the opportunity to work for companies, such as Nanovery. We look forward to watching their business flourish and become a part of the Biosphere and Newcastle Helix community.“ The Biosphere secured significant funding through the European Regional Development Fund (ERDF) as part of the European Structural and Investment Funds Growth Programme 2014-2020 and the Government’s Local Growth Deal through the North East LEP. Sign up for your daily BusinessLive North East newsletter You can get all the day's business news from the North East sent to your email inbox each morning. By signing up here, we will deliver the headlines from companies in Tyne and Wear, Northumberland, County Durham and Teesside straight to your email inbox every morning. Our specialist team of business writers will bring you stories from a range of sectors, reporting on companies large and small. Read More

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Nanovery

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nanovery is included in 3 Expert Collections, including Nanobiotechnology.



707 items

These companies apply nanotechnology to clinical medicine. They research or develop highly specific, nanoscale interventions to aid in screening, diagnosis, and treatment of biological systems.


Health Monitoring & Diagnostics

2,390 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Medical Devices

7,867 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.